These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 34313550)

  • 21. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
    Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
    Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum.
    Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A
    J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease.
    Lopetuso LR; Napoli M; Rizzatti G; Gasbarrini A
    Expert Opin Investig Drugs; 2018 Jun; 27(6):543-551. PubMed ID: 29865875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host and microbiota interactions are critical for development of murine Crohn's-like ileitis.
    Roulis M; Bongers G; Armaka M; Salviano T; He Z; Singh A; Seidler U; Becker C; Demengeot J; Furtado GC; Lira SA; Kollias G
    Mucosal Immunol; 2016 May; 9(3):787-97. PubMed ID: 26487367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
    Gloux K; Anba-Mondoloni J
    PLoS One; 2016; 11(1):e0148291. PubMed ID: 26824357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent dysbiosis of duodenal microbiota in patients with controlled pediatric Crohn's disease after resolution of inflammation.
    Pierce R; Jan NJ; Kumar P; Middleton J; Petri WA; Marie C
    Sci Rep; 2024 Jun; 14(1):12668. PubMed ID: 38830904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment-naive microbiome in new-onset Crohn's disease.
    Gevers D; Kugathasan S; Denson LA; Vázquez-Baeza Y; Van Treuren W; Ren B; Schwager E; Knights D; Song SJ; Yassour M; Morgan XC; Kostic AD; Luo C; González A; McDonald D; Haberman Y; Walters T; Baker S; Rosh J; Stephens M; Heyman M; Markowitz J; Baldassano R; Griffiths A; Sylvester F; Mack D; Kim S; Crandall W; Hyams J; Huttenhower C; Knight R; Xavier RJ
    Cell Host Microbe; 2014 Mar; 15(3):382-392. PubMed ID: 24629344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crohn's Disease, Host-Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches.
    Núñez-Sánchez MA; Melgar S; O'Donoghue K; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Ruiz-Alcaraz AJ; Ramos-Molina B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model.
    He Q; Li X; Liu C; Su L; Xia Z; Li X; Li Y; Li L; Yan T; Feng Q; Xiao L
    Appl Microbiol Biotechnol; 2016 May; 100(10):4485-94. PubMed ID: 26795965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses.
    Tyakht AV; Manolov AI; Kanygina AV; Ischenko DS; Kovarsky BA; Popenko AS; Pavlenko AV; Elizarova AV; Rakitina DV; Baikova JP; Ladygina VG; Kostryukova ES; Karpova IY; Semashko TA; Larin AK; Grigoryeva TV; Sinyagina MN; Malanin SY; Shcherbakov PL; Kharitonova AY; Khalif IL; Shapina MV; Maev IV; Andreev DN; Belousova EA; Buzunova YM; Alexeev DG; Govorun VM
    BMC Genomics; 2018 Dec; 19(1):968. PubMed ID: 30587114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease.
    Xia K; Gao R; Wu X; Sun J; Wan J; Wu T; Fichna J; Yin L; Chen C
    Front Cell Infect Microbiol; 2022; 12():864944. PubMed ID: 35493739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota.
    Cococcioni L; Panelli S; Varotto-Boccazzi I; Carlo DD; Pistone D; Leccese G; Zuccotti GV; Comandatore F
    Dig Liver Dis; 2021 Jan; 53(1):17-25. PubMed ID: 33189590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.